The autoimmune disease DEAP-hemolytic uremic syndrome

Seminars in Thrombosis and Hemostasis

Volumn 36, Issue 6, 2010, Pages 625-632

  Skerka, Christine ^a   Zipfel, Peter F ^a,b   Müller, Dominik ^c   Micklisch, Sven ^a   Riedl, Magdalena ^a,d   Zimmerhackl, Lothar Bernd ^d   Hofer, Johannes ^b,d  

^a HANS KNÖLL INSTITUTE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Autoantibodies; CFHR1; CFHR3; DEAP HUS

Indexed keywords

AUTOANTIBODY; COMPLEMENT FACTOR H; CYCLOSPORIN; FRESH FROZEN PLASMA; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB;

ANTIBODY TITER; AUTOIMMUNE DISEASE; CASE REPORT; CHILD; CLINICAL FEATURE; DEFICIENCY OF CFHR PLASMA PROTEINS AND FACTOR H AUTOANTIBODY POSITIVE HEMOLYTIC UREMIC SYNDROME; DIAGNOSTIC PROCEDURE; GENE DELETION; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LABORATORY TEST; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; THROMBOCYTOPENIA;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; AUTOANTIBODIES; BLOOD PROTEINS; CHILD; COMPLEMENT C3B INACTIVATOR PROTEINS; COMPLEMENT FACTOR H; GENE DELETION; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOLOGIC FACTORS; KIDNEY FAILURE, CHRONIC; MALE; PERITONEAL DIALYSIS; PLASMA EXCHANGE; RENAL DIALYSIS;

EID: 77957581739     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1262884     Document Type: Review

References (25)

1. Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med 2009 361 (17) 1676-1687
2. Skerka C, Licht C, Mengel M et al. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: indications for a disease spectrum and common pathogenic principles. Mol Immunol 2009 46 (14) 2801-2807
3. Józsi M, Licht C, Strobel S et al. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. Blood 2008 111 (3) 1512-1514
4. Dragon-Durey M A., Blanc C, Marliot F et al. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome. J Med Genet 2009 46 (7) 447-450
5. Abarrategui-Garrido C, Martnez-Barricarte R, López-Trascasa M, de Córdoba S R., Snchez-Corral P. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Blood 2009 114 (19) 4261-4271
6. Zipfel P F., Edey M, Heinen S et al. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet 2007 3 (3) e41
7. Dragon-Durey M A., Loirat C, Cloarec S et al. Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 2005 16 (2) 555-563
8. Lee B H., Kwak S H., Shin J I. et al. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency. Pediatr Res 2009 66 (3) 336-340
9. Le Quintrec M, Zuber J, Noel L H. et al. Anti-factor H autoantibodies in a fifth renal transplant recipient with atypical hemolytic and uremic syndrome. Am J Transplant 2009 9 (5) 1223-1229
10. Loirat C, Noris M, Frémeaux-Bacchi V. Complement and the atypical hemolytic uremic syndrome in children. Pediatr Nephrol 2008 23 (11) 1957-1972
11. Strobel S, Hoyer P F., Mache C J. et al. Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome. Nephrol Dial Transplant 2010 25 (1) 136-144
12. Józsi M, Strobel S, Dahse H M. et al. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. Blood 2007 110 (5) 1516-1518
13. Oppermann M, Manuelian T, Józsi M et al. The C-terminus of complement regulator factor H mediates target recognition: evidence for a compact conformation of the native protein. Clin Exp Immunol 2006 144 (2) 342-352
14. Skerka C, Zipfel P F. Complement factor H related proteins in immune diseases. Vaccine 2008 26 (Suppl 8) I9-I14
15. Zipfel P F., Skerka C. FHL-1/reconectin: a human complement and immune regulator with cell-adhesive function. Immunol Today 1999 20 (3) 135-140
16. Skerka C, Horstmann R D., Zipfel P F. Molecular cloning of a human serum protein structurally related to complement factor H. J Biol Chem 1991 266 (18) 12015-12020
17. Skerka C, Kühn S, Günther K, Lingelbach K, Zipfel P F. A novel short consensus repeat-containing molecule is related to human complement factor H. J Biol Chem 1993 268 (4) 2904-2908
18. Skerka C, Hellwage J, Weber W et al. The human factor H-related protein 4 (FHR-4). A novel short consensus repeat-containing protein is associated with human triglyceride-rich lipoproteins. J Biol Chem 1997 272 (9) 5627-5634
19. Józsi M, Richter H, Löschmann I et al. FHR-4A: a new factor H-related protein is encoded by the human FHR-4 gene. Eur J Hum Genet 2005 13 (3) 321-329
20. Skerka C, Timmann C, Horstmann R D., Zipfel P F. Two additional human serum proteins structurally related to complement factor H. Evidence for a family of factor H-related genes. J Immunol 1992 148 (10) 3313-3318
21. McRae J L., Cowan P J., Power D A. et al. Human factor H-related protein 5 (FHR-5). A new complement-associated protein. J Biol Chem 2001 276 (9) 6747-6754
22. Venables J P., Strain L, Routledge D et al. Atypical haemolytic uraemic syndrome associated with a hybrid complement gene. PLoS Med 2006 3 (10) e431
23. Heinen S, Hartmann A, Lauer N et al. Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood 2009 114 (12) 2439-2447
24. Zipfel P F., Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol 2009 9 (10) 729-740
25. Ståhl A L., Kristoffersson A, Olin A I. et al. A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome. Mol Immunol 2009 46 (11-12) 2236-2243